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STEM CELLS AND REGENERATION TECHNIQUES AND RESOURCES ARTICLE
Defined conditions for propagation and manipulation of mouse
embryonic stem cells
Carla Mulas1,*, Tüzer Kalkan1, Ferdinand von Meyenn2, Harry G. Leitch3,4, Jennifer Nichols1,5 and
Austin Smith1,6,*
ABSTRACT
The power of mouse embryonic stem (ES) cells to colonise the
developing embryo has revolutionised mammalian developmental
genetics and stem cell research. This power is vulnerable, however, to
the cell culture environment, deficiencies in which can lead to cellular
heterogeneity, adaptive phenotypes, epigenetic aberrations and
genetic abnormalities. Here, we provide detailed methodologies
for derivation, propagation, genetic modification and primary
differentiation of ES cells in 2i or 2i+LIF media without serum or
undefined serumsubstitutes. Implemented diligently, theseprocedures
minimise variability and deviation, thereby improving the efficiency,
reproducibility and biological validity of ES cell experimentation.
KEY WORDS: Differentiation, Embryonic stem cells, Pluripotency,
Self-renewal
INTRODUCTION
Mouse embryonic stem (ES) cells are cell lines derived from the pre-
implantation epiblast of mouse embryos (Boroviak et al., 2014;
Brook and Gardner, 1997; Evans and Kaufman, 1981; Martin,
1981). Under appropriate culture conditions they retain the
properties of their tissue of origin and can re-enter normal
development when introduced into morula- or blastocyst-stage
embryos (Bradley et al., 1984). Moreover, ES cells can readily be
genetically modified and clonally expanded. Advances such as
genome editing using CRISPR/Cas9 have expanded the
opportunities for multiplex and/or complex genome engineering
in ES cells (Andersson-Rolf et al., 2017; Yang et al., 2013). Their
properties make ES cells uniquely powerful tools, both for
generating genetically modified mice, and for experimental
dissection of fate choice in pluripotent cells. These attributes
depend entirely, however, upon the genetic and phenotypic fidelity
of ES cells during propagation.
ES cells were first derived in 1981 by culturing early mouse
embryos in conditions optimised for teratocarcinoma stem cells
(Evans and Kaufman, 1981; Martin, 1981). The capacity of ES cells
to contribute to chimaeras, colonise the germline and engender
healthy offspring was demonstrated in 1984 (Bradley et al., 1984),
establishing that they are non-transformed and, in all essential
aspects, genetically normal. This finding provoked a major effort to
introduce targeted genetic modifications into mice by implementing
homologous recombination in ES cells. It was not until the 1990s,
however, that the technology became relatively routine (for a
review, see Capecchi, 2005). A major reason for the time gap is that
ES cell cultures were frequently found to be aneuploid, particularly
after clonal selection. This problem gradually diminished as
appreciation spread of the relatively fastidious demands of ES cell
culture compared with other cell types (Robertson, 1987). In
particular, ES cells must be passaged frequently to avoid any
overgrowth, which confers advantage to genetically abnormal cells.
The original culture conditions for ES cells comprised co-culture
with a feeder layer of mitotically arrested embryonic fibroblasts and
medium containing carefully screened foetal calf serum (FCS)
(Robertson, 1987). This effective but complex systemwas simplified
with the discovery that a major contribution of feeders is to provide
the cytokine leukaemia inhibitory factor (LIF) (Smith et al., 1988;
Williams et al., 1988). Addition of LIF increases the robustness of
ES cell cultures on feeders and this remains a widely used system.
LIF can also support ES cell derivation and propagation without
feeders in either serum or bone morphogenetic protein (BMP)
(Nichols et al., 1990; Ying et al., 2003a). In these conditions,
however, the cultures are morphologically heterogeneous.
Moreover, the cells show fluctuating expression of several
transcription factors known to be expressed in the pre-implantation
epiblast and downregulated during peri-implantation development
(Chambers et al., 2007; Hayashi et al., 2008; Toyooka et al., 2008).
Thus, ES cells in these culture conditions do not correspond to a
discrete stage of embryonic pluripotency and the developmental
relevance of metastable gene expression remains unclear (Filipczyk
et al., 2015; Nichols and Smith, 2012; Smith, 2017). In contrast,
ES cells appear morphologically and molecularly relatively
homogeneous when maintained in defined medium in which
the Erk1/2 signalling pathway is blocked and glycogen synthase
kinase 3 is partially inhibited (Wray et al., 2010; Ying et al., 2008).
Under this dual inhibition, known as 2i, ES cells exhibit
transcriptome similarity to pre-implantation epiblast (Boroviak
et al., 2014). Importantly, unlike other conditions, use of 2i (or its
predecessor 3i) enables reliable derivation of authentic ES cells
from different strains of mice and also from another species,
the rat (Buehr et al., 2008; Kiyonari et al., 2010; Li et al., 2008;
Nichols et al., 2009a).
We have proposed that the defined culture system using the
highly specific 2i inhibitors corrals ES cells in a stable ‘ground state’Received 25 October 2018; Accepted 19 February 2019
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(Martello and Smith, 2014). The 2i platform has been widely
exploited to study signalling, gene regulation and network control of
naive pluripotency, and the transition path from pluripotency to
lineage commitment (Blaschke et al., 2013; Carey et al.,
2014; Dunn et al., 2014; Ficz et al., 2013; Habibi et al., 2013;
Hackett et al., 2017; Hayashi et al., 2012, 2011; Kalkan et al.,
2017; Kumar et al., 2014; Leitch et al., 2013a; Marks et al., 2012;
McEwen et al., 2018 preprint; Mulas et al., 2017; Murakami et al.,
2016; Semrau et al., 2017). Importantly, male ES cells maintained
in 2i can retain a euploid karyotype and germline chimaera
competency over multiple passages with similar efficiency to
cells cultured in serum (Ying et al., 2008; Nichols et al., 2009a;
Kiyonari et al., 2010; Leitch et al., 2010, 2013b,a; Leeb et al., 2012;
Morgan et al., 2013; Jakubczik et al., 2016; Kalkan et al.,
2017; Zhang et al., 2018). Interestingly, ES cells show lower
global DNA methylation in 2i than in serum (Ficz et al., 2013;
Habibi et al., 2013; Leitch et al., 2013a). Female ES cells are
vulnerable to severe hypomethylation (Choi et al., 2017a) and loss
of methylation imprints in either 2i or serum, which can reduce their
chimaera contribution (Yagi et al., 2017). Male ES cells on the other
hand can retain relatively normal methylation imprints (Fig. 1),
although loss of specific differentially methylated regions (DMRs)
has also been reported in both serum and 2i cultures (Choi et al.,
2017b; Dean et al., 1998). Genetic background may be one
component influencing loss of imprinted DMRs. Another important
factor may be levels of culture stress or stimulation due to
differences in media composition and cell handling between
laboratories, even when using apparently similar conditions. As
with any cells in vitro, ES cells are inherently liable to acquire
genetic and epigenetic adaptations or abnormalities if subjected
to untoward selective pressures. Vulnerability to environmental
stress may be enhanced in serum-free culture. Consequently,
apparently minor variations in media formulation or culture
procedures may give rise to discrepant findings. Reports of
subpopulations and cell cycle heterogeneity in 2i culture
(Kolodziejczyk et al., 2015) may likewise be influenced by
particular culture practices.
The field could benefit, therefore, from a stringent methodology
for ES cell culture. To that end, we detail here standardised
media composition and cell handling procedures for robust
propagation and genetic manipulation of mouse ES cells using 2i
in defined medium.
RESULTS AND DISCUSSION
Propagation of ES cells without serum factors or feeders
Aim
The aim of this procedure is to expand undifferentiated cells in 2i or
2i/LIF (Ying et al., 2008). The anticipated outcome is actively
growing colonies of uniform size that are evenly distributed across
the dish, with no signs of differentiation, and that can be passaged
by enzymatic dissociation and expanded continuously. Note that in
defined medium cells are generally less tolerant to suboptimal
media conditions or environmental perturbations than in the
presence of serum, serum substitutes such as KnockOut Serum
Replacement (KSR), or feeders. This susceptibility may manifest as
spontaneous differentiation and/or cell death. Cells should not be
kept out of the incubator any longer than necessary or exposed to
varying incubator environments.
Materials
Accutase
0.1-0.2% gelatine in PBS or 10 µg/ml laminin in PBS
Wash medium (DMEM/F12 + BSA; see Table S1)
2i or 2i/LIF [hereafter referred to as 2i (±LIF)] in N2B27 (see
Table S1 for media formulation and suggested suppliers)
Haemocytometer
Tissue culture treated plates
Falcon tubes
Bench centrifuge
Humidified incubator at 7% CO2 and 37°C
Protocol: routine passage of ES cells from a 6-well plate
1. Coat plates or wells with 0.1-0.2% gelatine in the incubator
for a minimum of 15 min.
2. Pre-warm necessary volume of 2i (±LIF) or other culture
medium, wash medium and Accutase to 37°C. Note: avoid
leaving 2i medium or Accutase at 37°C for too long.
3. Remove all gelatine from plates or wells and replace with
warm medium. Return to the incubator to pre-equilibrate (not
necessary but might help survival, especially for ES cells of
non-permissive strains, compromised mutants or when
plating at low density). Drying the plates is not necessary.
4. Aspirate medium gently but completely from cells and add
0.5 ml of Accutase per well. Avoid drying the cells.
Fig. 1. Imprinted control region (ICR) methylation levels in mouse ESCs. (A,B) Average CpG methylation levels at known ICRs were quantified in whole
genome bisulphite sequencing (WGBS) data sets from an ES cell line maintained in 2i (no LIF) (Kalkan et al., 2017; GEO accession number GSE92273) (A) and
from an ES cell line maintained in 2i/LIF (Ficz et al., 2013; GEO accession number GSE42923) (B). Both datasets are derived from inbred 129 strain lines. The
WGBS datasets were processed as described previously (von Meyenn et al., 2016) and the mean±s.d. of three experiments are shown. The mean global CpG
methylation levels in each condition are shown (red dashed line). These observations are in agreement with previous reports that methylation at three
DMRs ismaintained in an ES cell line derived andmaintained in 2i/LIF and an allele-specific assay confirmation of normal methylation pattern at the same regions
in 2i/LIF-derived embryonic germ cells (Leitch et al., 2013a).
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5. Incubate with Accutase (see Table 1) at room temperature for
4-6 min until colonies decompact and detach. Tap plate to
ensure detachment and initial dissociation.
6. Add 1 ml of wash buffer and pipette up and down (without
touching the bottom of the dish) 10-20 times in order to
obtain a single cell suspension. Try to minimise the
formation of bubbles. Tip: check under the microscope to
ensure single cell suspension.
7. Transfer cell/Accutase/wash suspension to a Falcon tube
containing 6 ml of wash medium (see Table 1).
8. Centrifuge cells at 300 g for 3.5 min.
9. Aspirate supernatant with care, removing as much liquid as
possible without disturbing the pellet.
10. Re-suspend cell pellet by pipetting up and down 10-15 times
in 0.5-2 ml of 2i (±LIF) medium, ensuring a single cell
suspension is obtained.
11. Count number of cells/ml and plate appropriate number of
cells (see Table 1). Slide plate back and forth across a flat
surface to distribute cells evenly, then place carefully in
incubator. Do not disturb for several hours.
Notes
Cell density will have a significant effect on metabolism, cell cycle
and differentiation kinetics, amongst other factors. This is,
therefore, a key parameter to monitor. We have observed that
culture at high density or colony overgrowth can compromise ability
to differentiate and that this effect may become irreversible.
Overgrowth of cells in FCS/LIF conditions is also associated
with impaired capacity of differentiation and karyotypic instability,
but in defined conditions ES cells must be passaged at smaller
colony sizes than in FCS- or KSR-containing medium. A single
period of overgrowth may induce a permanent change, even
if undifferentiated morphology is retained. Specifically, even if
overgrown cells regain refractile domed morphology after
passaging, they may be compromised. Two key parameters
should be kept relatively constant: (1) the density at which cells
are plated after each split; (2) the frequency with which cultures are
split. Representative images of cultures ready to be passaged are
shown in Fig. 2.
The following cell concentrations are routinely used: for
maintenance of cells, 1.5-3.0×104 cells/cm2; for most
experiments: 1.5×104 cells/cm2 (see below for differentiation).
See also Table 1. It is highly recommended to count cell numbers at
every split to avoid overgrowing cells and to monitor growth rate
(see Fig. 2 for representative images).
In routine culture, cells should be split every 2-3 days (Fig. 2).
Healthy cultures double every 12-14 h (Carey et al., 2014). ES cells
in 2i have a substantial proportion of cells in G1 phase (Fig. 3)
(Huurne et al., 2017). This is in contrast to FCS cultures, in which
∼70% of cells are in S phase (Huurne et al., 2017). Even if plated at
lower/clonal density, colonies should not be allowed to grow for
more than 4-5 days before passaging.
If passaging is delayed beyond 2 days, medium should be
renewed on day 3, and any day thereafter.
The quality of N2B27 must be monitored. Signs of suboptimal
N2B27 include flattening of colonies, cells detaching, reduced
proliferation rate, or increased cell death.
ES cells from certain genetic backgrounds (e.g.C57BL/6) require
2i/LIF in order to be stably propagated long term, whereas others,
such as 129 strains, can be propagated in 2i alone or in single
inhibitor with LIF. LIF invariably increases colony formation after
low-density plating. The addition of LIF alters the kinetics of
differentiation, however, delaying the process by ∼12 h (Nett et al.,
2018). Certain mutant cell lines (e.g. those carrying Etv4/5 gene
deletions), are sensitive to MEK inhibition and show more robust
proliferation in CH/LIF (LIF containing CHIR99021) (Kalkan
et al., 2019). To convert cells between 2i, CH/LIF and PD/LIF (LIF
containing PD0325901), two passages over 4-6 days are sufficient.
PD/LIF cells typically show amore flattenedmorphology than those
Table 1. Volumes and plating cell density for different size wells
48-well 24-well 12-well 6-well T25 T75 T150
Area (cm2) 0.95 1.9 3.8 9.5 25 75 150
Cells/well 14.25 K 28.5 K 57 K 142.5 K 375 K 1.125 M 2.25 M
Culture media (ml) 0.2-0.3 0.5-1 1-2 2-4 5-7 ∼12.5 ∼25
Accutase/well (ml) 0.060 0.15 0.3 0.5 1 2.5 4
Wash buffer (ml) 1 2 4 6 10 20 25
K, ×103; M, ×106.
Fig. 2. Representative images of ES
cells in 2i at different densities on day
2 and day 3. Blue box highlights the
range of cell densities ideal for splitting.
Note refractile colony edges on day 2,
which are lost in overgrown colonies at
day 3. Scale bars: 0.5 mm.
3
STEM CELLS AND REGENERATION Development (2019) 146, dev173146. doi:10.1242/dev.173146
D
E
V
E
LO
P
M
E
N
T
grown in conditions containing CH. Because culture in 2i/LIF is
most robust, cells can be kept in 2i/LIF for routine passaging, and
transferred to other conditions (e.g. 2i or PD/LIF) for one or two
passages before experimental analyses. The cell densities reported
above work well for all medium conditions.
Cell lines can either be derived in defined conditions (see below)
or adapted from conventional FCS/LIF (with or without feeders)
conditions. When converting cells from FCS/LIF, we recommend
plating cells first in FCS/LIF and changing media to 2i or 2i/LIF
after 24 h. Cell death, mainly associated with elimination of
differentiating cells, is often observed for the first few days, but
stable homogeneous cultures can be established within one or
two passages.
Cells should be routinely maintained without any antibiotics, in
keeping with good tissue culture practice (Freshney, 1994).
Antibiotics can mask low level microbial infections and may have
unknown effects on cell metabolism and gene expression.
Mycoplasma testing should be carried out frequently and on all
newly generated or obtained lines using PCR assays and
commercial kits. If mycoplasma is detected, the cultures should
be discarded (Markoullis et al., 2009).
It is important to maintain two types of cell line stock. Primary
stocks are the lowest passage cells available [passage (p) 4-8 for
embryo-derived cell lines], that have been genotyped, mycoplasma
screened, have at least ∼80% diploid cells (40XY or 40XX) and
show uniform morphology. These are kept in liquid nitrogen for
long-term storage. Secondary stocks are more numerous at slightly
higher passage number (p10-15). These stocks can be kept short
term at −80°C and are used for routine experiments. Cells should
not normally be passaged beyond 30. However, we have generated
high contribution chimeras that give germline transmission after
multiple passages of mouse ES cells (p30+), embryonic germ cells
(p15+), and haploid ES cells (p20+) in 2i/LIF.
Accutase is routinely used because it is gentler than trypsin,
results in a single cell suspension and does not require serum
inactivation. TrypLE reagents may also be used, although these
occasionally result in incomplete dissociation. Trypsin can be used,
but we recommend adding ∼5% FCS to the wash medium (see
Table S1) to ensure complete inactivation, or doubling the volume
of wash medium, or increasing the BSA concentration.
Attachment of poorly adherent cells, a feature of some
mutants and non-129 strains (e.g. CBA, NOD, DBA, etc.),
can be improved by plating onto laminin-coated plates. For this,
coat plates with laminin solution (∼10 µg/ml in PBS) for a
minimum of 2 h at 37°C, before aspirating the solution and
adding the culture medium.
DMEM/F12 and Neurobasal buffer can be used at 5-10% CO2.
We use 7% CO2 for compatibility with FCS cultures maintained in
GMEM. In the presence of B27 we have not observed any
advantage of low O2 compared with ambient atmosphere.
Colony-formation assay
Aim
The colony-formation assay is a key functional test in ES cell
biology. Cultures are dissociated to a single cell suspension and
plated at very low (clonal) density, and the number of colonies that
form is determined after several days. This assay can be used as
a diagnostic tool for media quality control, and experimentally
for determining the proportion of undifferentiated cells in a
differentiation or reprogramming study or following a genetic/
chemical perturbation, or in a modified culture environment. See
Fig. 3 for an example.
Materials
Accutase
10 µg/ml laminin in PBS
Wash medium
2i/LIF (see Table S1 for media formulation and suggested
suppliers)
FCS+LIF
Haemocytometer
Tissue culture treated plates
Falcon tubes
Centrifuge
Humidified incubator at 7% CO2 and 37°C
Alkaline phosphatase staining kit
Protocol
1. Coat 12-well plates (provide three wells per sample) with
laminin (∼10 µg/ml in PBS) for a minimum of 2 h at 37°C.
At clonal density, laminin helps colonies remain attached for
the duration of the experiment.
2. Pre-warm Accutase, wash medium, and culture medium
(e.g. 2i/LIF).
3. Before starting, aspirate laminin and add 1 ml of 2i/LIF per
well. Return plate to the incubator in the meantime to
equilibrate medium.
4. Aspirate medium from cells and quickly add appropriate
volume of Accutase.
5. Incubate with 1 volume of Accutase at room temperature
(RT) for 4-6 min (1 min after the colonies have detached).
6. Add 1 ml of wash medium and pipette up and down
10-20 times in order to obtain a single cell suspension.
Tip: check under the microscope to ensure single cell
suspension.
7. Transfer cell/Accutase/wash suspension to a Falcon tube
containing 5 volumes of wash medium.
8. Centrifuge cells at 300 g for 3.5 min.
9. Aspirate supernatant with care, removing as much liquid as
possible without disturbing the pellet.
10. Re-suspend cell pellet in 0.5-2 ml of culture medium (e.g.
2i/LIF).
11. Count number of cells/ml.
12. Plate 400 cells/well in prepared medium. If necessary,
carry out two sequential 1:10 dilutions of the cell to improve
accuracy, and aim to pipette ∼50 µl of cell suspension
per well.
Fig. 3. Typical cell cycle profile of day 2ES cells plated at 1.5×104 cell/cm2.
Cells were stained with propidium iodide (PI) and the Click-iT EdU kit according
to manufacturer’s instructions. Graph shows quantification over two
independent experiments, with two separate lines in each.
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13. Slide plate back and forth across a flat surface to distribute
cells evenly, then place carefully in incubator.
14. After 4-5 days, perform alkaline phosphatase staining
according to manufacturer’s instructions, let dry, image
plate and count the number of colonies.
Notes
The use of 12-well or 6-well plates is advisable. Plate 400 cells in
12-well plate, and 800 in 6-well plates. It is recommended to
perform at least three technical replicates per condition as high
variability can occur when plating small numbers of cells.
Fluorescence-activated cell sorting of cells directly onto plates can
also be used to reduce technical variability.
Colonies can detach easily; therefore, add fixative gently.
Leaving cells for >5 days will increase the likelihood of colony
detachment.
We also recommend performing colony-formation assays in
parallel FCS/LIF medium and analysing plates by alkaline
phosphatase staining on day 3/4. Monitor cultures to make sure
colonies do not merge. In FCS/LIF conditions, differentiating cells,
which would not survive in 2i/LIF, will persist and contribute to
mixed or wholly alkaline phosphatase-negative colonies. This
experiment can serve as a control for plating efficiency and
differentiation potential. Fig. 4 shows representative images of
colony assays in 2i/LIF and FCS/LIF.
Typically, we expect wild-type cells maintained in 2i or 2i/LIF to
have a clonogenic capacity of ∼70-80% when plated in 2i/LIF in
optimal media (all alkaline phosphatase positive) with minimal
differentiation.
Exit from naïve pluripotency
Aim
Examining the kinetics of exit from naïve pluripotency can inform
whether a particular perturbation (genetic, chemical or mechanical)
accelerates, delays or blocks transition to differentiation (for
examples, see Kalkan et al., 2019; Li et al., 2017; Martello et al.,
2013; Miller et al., 2016; Nett et al., 2018; Niwa et al., 2009; Wray
et al., 2011). This system can also be used for genetic screens to
identify regulators of pluripotency progression (Betschinger et al.,
2013; Leeb et al., 2014; Li et al., 2018; Villegas et al., 2018; Yang
et al., 2012).
Materials
Accutase
0.1-0.2% gelatine in PBS or 10 µg/ml laminin in PBS (for
timecourse studies longer than 48 h, laminin coating is
recommended for better attachment)
Wash medium
2i (±LIF) in N2B27
N2B27 (see Table S1)
PBS
Haemocytometer
Tissue culture treated plates
Falcon tubes
Bench centrifuge
Humidified incubator at 7% CO2 and 37°C
Protocol: timecourse study over ∼48 h
1. Coat 24-well plates or wells with 0.1-0.2% gelatine in the
incubator for a minimum of 15 min. Allow for two or three
wells per condition (technical repeats). Use a separate plate for
each time point.
2. Pre-warm necessary volume of 2i (±LIF) or other culture
medium, wash medium and Accutase to 37°C. Note: avoid
leaving 2i medium or Accutase at 37°C for too long.
3. Remove gelatine from plates or wells and replace with warm
medium. Return to the incubator to pre-equilibrate (not
necessary but might help survival, especially for ES cells of
non-permissive strains, compromised mutants or when
plating at low density).
4. Split cells as indicated previously, re-suspend cell pellet in
0.5-2 ml of 2i (±LIF) and count number of cells/ml.
5. Plate 30,000 cells per well of a 24-well plate. Slide plate back
and forth across flat surface to distribute cells evenly, then
place carefully in incubator. Do not disturb for several hours.
6. After 12-24 h, aspirate medium from cells and add 0.5-1 ml of
sterile PBS. Aspirate PBS and replace with pre-warmed
N2B27. Perform media replacement steps gently to avoid
detaching cells.
7. Analyse cells at the appropriate time points.
Notes
The exact time at which 2i(±LIF) is replaced by N2B27 to initiate
exit from naïve pluripotency is flexible. However, it should be kept
constant across experiments. Higher density cultures transition
more slowly.
Different downstream tests can be performed to determine the
kinetics of transition and different time points can be chosen (for
examples, see Betschinger et al., 2013; Kalkan et al., 2017; Mulas
et al., 2017). Assays include: (1) colony-formation assay (see
‘Colony-formation assay’ section, Fig. 5A), a key functional assay
for exit of the ES cell state, which occurs asynchronously across the
population, used to indicate what proportion of the population still
remains responsive to naïve ES cell conditions; (2) flow cytometry
using reporter cell lines (e.g. Rex1::GFPd2, Nanog-GFP, etc.;
Fig. 5B,C); (3) RT-qPCR to determine the expression of genes
associated with the different stages of pluripotency or
Fig. 4. Representative images of clonal
assays in 2i/LIF and FCS/LIF conditions.
Insets to the right show magnified views of
individual colonies and suggested
classification in the case of FCS/LIF.
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differentiation; (4) fixation and immunostaining for proteins
associated with ES cells (e.g. Nanog, Klf4, etc.) or transition
[Oct6 (Pou3f1), Otx2, etc.] (Fig. 5D).
It is recommended to analyse multiple time points. Typically,
∼25-36 h after withdrawal of self-renewal conditions offers a time
window during which both delayed and accelerated transition can
be evaluated, as ∼50% of the wild-type cell population should
remain responsive to 2i/LIF and positive for Rex1GFPd2. The
exact timing for each experiment will depend on the starting
culture condition (e.g. 2i versus 2i/LIF), the batch of N2B27, cell
plating density, etc.
Neural differentiation
Aim
Monolayer neural differentiation is a simple and well-
characterised system (Ying et al., 2003b) and, under the right
conditions, an efficient one. Therefore, it can be used to
determine competence for differentiation and to examine gene
expression dynamics.
Materials
Accutase
∼10 µg/ml laminin in PBS
Wash medium
2i (±LIF)
N2B27 (see Table S1)
Haemocytometer
Tissue culture treated plates
Falcon tubes
Centrifuge
Humidified incubator at 7% CO2 and 37°C
Standard protocol
1. Coat plates with laminin (∼10 µg/ml in PBS) overnight
(ideally) or for a minimum 2 h at 37°C.
2. Aspirate laminin (do not wash) and add appropriate volume
of N2B27. Return to the incubator to pre-equilibrate. Note:
pre-equilibration is not necessary but it helps survival.
3. Split cells, re-suspend in N2B27 and count them.
4. Plate directly in N2B27 onto laminin-coated plate at a density
of 1.0×104 cells/cm2 or 1.2×104 cells/cm2 for flow-sorted
cells. Optional: adding 1 µg/ml laminin directly to N2B27,
before plating cells in laminin-coated plates, can help with
adhesion.
5. Change media to fresh N2B27 on day 2 and every day
thereafter.
Alternative protocol for poorly adherent cells
1. Coat plates with laminin (∼10 µg/ml in PBS) overnight
at 37°C.
2. Aspirate laminin (do not wash) and add appropriate volume
of 2i (+LIF). Return to the incubator to pre-equilibrate.
Note: pre-equilibration is not necessary but it helps
survival.
3. Split cells as late as possible in the day and plate in 2i or 2i/LIF
onto laminin-coated plate at a density of 1.0×104 cells/cm2 or
1.2×104 cells/cm2 for sorted cells. Optional: adding 1 µg/ml
laminin directly into N2B27 can help with adhesion.
4. As early as possible on the next day, gently wash cells with
PBS before changing the media to N2B27.
5. Change media to fresh N2B27 on day 2 and every day
thereafter.
Notes
Little or no death should be observed until cells become confluent
(Fig. 6B). Significant death at day 3 is a sign of poor-quality media
(see ‘Batch testing N2B27’ section) or incorrect plating density.
Certain lines may require further optimisation of plating density to
minimise cell death. ES cells derived from certain strains might
show more cell death compared with 129 or mixed strains. When
Fig. 5. Example dataof exit frompluripotencyexperiment. (A)Colony-formation assay. Cells were differentiated for 36 h in four different conditions; PD03,MEK1/2
inhibitor PD0325901 (1 µM); BI, RSK inhibitor BI-D1870 (3 or 6 µM); DMSO, carrier control. (B) Representative downregulation kinetics of Rex1::GFPd2 cells
plated inN2B27, starting from2i (noLIF) conditions.Green dotted line indicates arbitrary threshold. (C)Use of theRex1::GFPd2 reporter system todetermine the effect
of two different inhibitors (PD03, MEK1/2 inhibitor PD0325901 at 1 µM; PD17, FGF receptor inhibitor PD173074 at 100 nM) on exit kinetics. (D) Fixing and
immunostaining for Nanog protein, to quantify the delay in transition associated with knockdown of the Tcf7l1 transcription factor by siRNA.
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troubleshooting differentiation, we recommend plating cells at three
different cell densities (e.g. 0.75×104 cells/cm2, 1.0×104 cells/cm2
and 1.5×104 cells/cm2), monitoring cell death at day 3-4 and
quantifying Sox1-positive cells at day 4-5. Efficient conditions
typically yield ∼90% Sox1-positive cultures on day 5 with little
non-neural differentiation (Fig. 6C).
The efficiency and timing of differentiation can be assessed by
using the Sox1GFP reporter cell line (Ying et al., 2003b) or by
measuring the expression of different neural markers such as Sox1
protein by immunofluorescence over time (Fig. 6A,C). When
starting from 2i (no LIF) cells, the following changes in
transcription factor expression can be anticipated: day 1,
predominantly Oct4 (Pou5f1) positive, Sox2 positive, Sox1
negative; day 3, predominantly Sox2 positive (cells should be
either Oct4 or Sox1 positive, as their expression is mutually
exclusive), 30-50% Sox1GFP-positive cells; day 4-5, mostly Sox1-
positive cells and 80-90% Sox1GFP-positive cells. Tuj1 (Tubb3)-
positive cells should appear on day ∼6. Differentiation of cells
cultured in 2i+LIF will be delayed by ∼1 day.
Low cell density is essential for efficient differentiation (Fig. 6A).
If starting from 2i+LIF or if cells have to be pre-plated before
initiating differentiation, there will be more proliferation
before exiting pluripotency. Cell density can be lowered to
0.8×104 cells/cm2.
The quality of N2B27 should be monitored. Batches should be
specifically tested for neural differentiation. Certain mouse strains
benefit from high insulin N2B27 (see Table S1).
Failure to change media regularly, or plating cell density higher
than 1.2×104 cells/cm2, can result in mixed differentiation (most
obviously indicated by cells undergoing spontaneous contractions)
and in persistence of undifferentiated ES cells.
CRISPR/Cas9 mutagenesis
Aim
CRISPR/Cas9 (Cong et al., 2013; Jinek et al., 2012) allows for fast
and efficient targeted mutagenesis of ES cells. As per routine ES
cell culture, it is important to avoid overgrowing cells as they might
develop phenotypes unrelated to the genetic perturbation. It is
advantageous to use clones that go through the targeting process but
that have not been edited as control cell lines. Depending on the
plasmid used, transfected cells can be selected either using drug
selection or by sorting for the expression of GFP.
Materials
Accutase
0.1-0.2% gelatine
Wash medium
FuGene
gRNA vectors
FCS (optional)
N2B27, 3 µM CHIR99021, LIF (hereafter referred to as CH/LIF;
alternatively use 2i/LIF; see Table S1 for media formulation
and suggested suppliers)
Penicillin and Streptomycin (PenStrep)
Puromycin (depending on the strategy)
Haemocytometer
Tissue culture treated 3.5 cm diameter plates or 12-well plates
and 96-well plates for single clone picking
Falcon tubes
Centrifuge
Humidified incubator at 7% CO2 and 37°C
Cell sorter (depending on the strategy)
Transfection protocol
1. Pre-warm CL, wash medium and Accutase at 37°C. Allow
FuGene to equilibrate at RT.
2. Coat 3.5 cm diameter, low-edge dish or wells of a 12-well
plate with 0.1-0.2% gelatine and place in incubator for a
minimum of 15 min.
3. Prepare transfection mixes as follows. Mix A: 250 ng
gRNA 1, 250 ng gRNA 2, 200 μl CH/LIF (control: 200 μl
CH/LIF); Mix B: 1 μl FuGene, 200 μl CH/LIF (control: 1 μl
FuGene, 200 μl CH/LIF).
4. Split cells as previously indicated.
5. Just before counting cells, combine mix A and B to obtain
400 µl transfection reaction. Incubate for 5-15 min at RT
(longer incubation might reduce transfection efficiency).
6. Count cells.
7. Aspirate gelatine from wells and plate 300,000 cells in 1.6 ml
of CH/LIF.
8. Add 400 µl of transfection reaction to cells and mix.
Fig. 6. Representative images of cells at different stages of neural
differentiation. (A) Immunostaining for Sox1 and Oct4 on day 1-3 of neural
differentiation. (B) Phase contrast images showing representative morphology
of early day 3 neural differentiation for two different cell lines (live cultures).
Little cell death should occur during the first 1-3 days of differentiation. Cell
death might become apparent once cultures become confluent.
(C) Immunostaining for Sox1 and the post-mitotic marker Tuj1 on days 4 and 6
of differentiation. Scale bars: 0.5 mm.
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9. Ensure even distribution of cells by sliding the dish across a
flat surface vertically and horizontally.
Puromycin selection
1. The day after transfection, change media and add CH/
LIF+1 µg/ml puromycin.
2. 48 h after transfection, change medium to CH/LIF+0.5 µg/ml
puromycin for a further 24 h. This should kill all cells in the
control plate.
3. 72 h after transfection, change medium to CH/LIF+PenStrep.
4. Day 6-8 after transfection, pick clones for expansion. The
control plate should be almost completely clear. Colony
number per plate ranges from 30 to 100+ depending on the
gRNA.
GFP sorting
1. The day after transfection, change media and add fresh CH/LIF.
2. 48 h after transfection, sort single GFP-positive cells into a
96-well plate in CH/LIF+PenStrep.
3. 72 h after transfection, change medium to fresh CH/
LIF+PenStrep.
Modifications required for generating knock-in with CRISPR/Cas9
1. Design gRNAs and clone into nickase plasmid
[pSpCas9n(BB)-2A-Puro (PX462) V2.0; Addgene plasmid
#62987]. The distance between the gRNA target sequences
should be kept <200 bp for efficient insertion.
2. Different approaches exist for designing targeting vectors. In
our hands, homology arms of 1.5 kb for the 3′ end, and 3 kb
for the 5′ end work efficiently, but shorter homology arms
might be used. Both gRNA target sequences should be absent
in the targeting vector sequence to avoid cleavage. The
amount of targeting vector should be minimised to avoid
random integration.
3. A 6-well plate format should be used with a cell concentration
of 1-2×105 cells and a final volume of 1.6 ml before adding
transfection reagent.
4. Transfection mixes should be prepared as follows. Mix A:
900 ng gRNA 1, 900 ng gRNA 2, 200 ng targeting vector,
400 μg CH/LIF; Mix B: 6 μl FuGene, 400 μl CH/LIF.
Single colony picking and expansion
Typically, 12-24 clones are picked per transfection and this is
sufficient to obtain at least two targeted lines.
1. Coat wells of a 96-well plate (plate 1) with 0.1-0.2% gelatine
in the incubator for a minimum of 15 min.
2. Pre-warm CH/LIF+PenStrep and Accutase.
3. Add 15 µl of PBS to the bottom of each well of a new 96-well
plate (plate 2).
4. Under an inverted or dissection microscope in a flow cabinet,
pick individual colonies and deposit in a well of plate 2
(containing PBS). If picking 36+ colonies, it is recommended
to pick them in smaller batches. Do not leave colonies in PBS
for more than 15-20 min. Pick colonies of different sizes.
Change pipette tips between picks.
5. Add 30 µl of Accutase to each well of plate 2 and incubate for
∼5-10 min shaking occasionally.
6. Add 150 µl of CH/LIF+PenStrep to each well of plate 2
(containing the picked clones) and pipette up and down to
separate colonies into single cells.
7. Aspirate gelatine from plate 1 (previously prepared).
8. Transfer all the cell suspension from plate 2 onto plate 1.
Evenly disperse cells by sliding plate vertically and
horizontally across a flat surface.
9. Next day, gently change media to fresh CH/LIF+PenStrep by
aspirating most of the media, leaving just enough to cover
cells. Take care not to detach cells.
Expansion of primary clones
1. Coat a sufficient number of wells in a 48-well plate with
0.1-0.2% gelatine solution for at least 15 min at 37°C.
2. Warm Accutase and CL+PenStrep at 37°C.
3. Aspirate gelatine fromwells of the 48-well plate and add 200 µl
of CH/LIF+PenStrep. Return plate to the incubator to
pre-equilibrate.
4. Aspirate media from 96-well plates (plate 1, containing
primary clones) and add 50 µl of Accutase. Incubate for
∼6 min until all the colonies have detached from the plate.
5. Add 100 µl of CH/LIF+PenStrep and pipette up and down to
obtain single cell suspension.
6. Transfer 100 µl of cell suspension to the pre-equilibrated
48-well plate. Ensure uniform distribution of cells before
placing in the incubator.
7. Optional: The remaining cell suspension in the 96-well plate
can be used for genotyping. Add 150 µl of CH/
LIF+PenStrep+1% FCS to each well of the original 96-well
plate. Cells can be harvested on day 2 for genomic DNA or
mRNA purification and genotyping.
Notes
This protocol employs SpCas9(BB)-2A-Puro (PX459) (Addgene
plasmid #62988) or pSpCas9(BB)-2A-GFP (PX458) (Addgene
plasmid #48138).
Set up transfections late in the day in order to be able to change
media within ∼16 h post-transfection.
Each transfection will require 300,000 cells per well (round dish
with 3.5 cm diameter and a low edge to facilitate colony picking).
Include one extra well as a control.
Transfections in N2B27/CHIR99021/LIF (CH/LIF) result in
better attachment and improved survival during selection when
targeting some genes but in general 2i/LIF is effective. The addition
of 1% FCS can help cell adhesion, especially after picking clones,
but it is not necessary for most lines.
For efficient knockout, we routinely use two gRNA constructs per
gene and FuGene HD transfection reagent (Promega, E2311). Two
genes can be targeted at the same time by transfecting four gRNA
constructs. In such cases, the amount of FuGene HD can be doubled.
Include a well containing only FuGene and no gRNA as a control
for drug selection or cell sorting.
Do not let primary colonies overgrow as this will increase the
chances of cell lines becoming compromised.
siRNA knockdown in ES cells
Aim
Efficient transfection of siRNA for knockdown of single or multiple
genes in cells grown in serum-free conditions.
Materials
Accutase
Wash medium
2i (±LIF) (see Table S1 for media formulation and suggested
suppliers)
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0.1-0.2% gelatine in PBS or ∼10 µg/ml laminin in PBS
Haemocytometer
Tissue culture treated 24-well plates
Centrifuge
Humidified incubator at 7% CO2 and 37°C
siRNA preparation
1. Dissolve Qiagen FlexiTube siRNAs in 50 μl RNAase-free
water to obtain a 20 μM stock solution.
2. Mix equal volumes of each siRNA to obtain a 20 μM pool
siRNA solution (each siRNA at 5 μM).
3. Keep on ice throughout.
Protocol
Set up late afternoon.
1. Coat a sufficient number of wells in 24-well plates with
gelatine solution for at least 15 min at 37°C. If carrying out
neural differentiation after siRNA transfection, laminin
coating is recommended instead.
2. Incubate 0.5 μl pooled siRNAs in 50 µl of 2i and 0.5 μl
Lipofectamine RNAiMAX (Life Technologies, 13778075) in
50 μl of 2i medium. After 2-3 min, mix and incubate for
20 min at RT (while splitting the cells).
3. Split cells and dilute to give 3.0×104 cells in 400 µl of 2i for
each well.
4. Aspirate gelatine from 24-well plate and combine 100 µl of
siRNA solution with 400 µl of cell suspension per well.
5. Incubate overnight.
6. Next morning, wash gently with PBS and change medium
and/or collect cells for RT-qPCR to determine knockdown
efficiency. Note: differentiation can be initiated at this point
by changing medium to N2B27.
Notes
Transfect Rex1::GFPd2 cells with control orGFP siRNA and analyse
by flow cytometry after overnight incubation. An acceptable
transfection efficiency is >90% (Fig. 7). Note that this control is
sensitive becauseGFPd2protein is destabilisedwith a half-life of∼2 h.
PenStrep- or serum-containing media cannot be used as this
inhibits transfection.
Use the same media to prepare the transfection mix and culture
cells (best results in 2i, without LIF).
Do not leave the cells in the transfection media for more than
∼16 h or they will die.
Cells must be actively replicating; using confluent cells (large
colonies) will decrease the transfection efficiency.
Control siRNAs are as follows: GFP (custom-made),
GCAAGCUGACCUGAAGUUCA; control (AllStars negative
control siRNA, Qiagen, SI03650318).
ES cell derivation
Aim
Derivation of ES cell lines from individual embryos, in serum-free
conditions (Batlle-Morera et al., 2008; Nichols and Jones, 2017;
Nichols et al., 2009b).
Materials
KSOM medium (Millipore, MR-106-D) or Blast (Origio,
83060010)
M2 medium (Millipore MR-015-D)
2i/LIF medium in N2B27 (see Table S1)
2i/LIF in M2
Tyrode’s solution, acidic (Sigma-Aldrich T1788 or Millipore
MR-004-D)
Rabbit anti-mouse antiserum (Sigma-Aldrich, M5774)
Complement sera from guinea pig, lyophilised [Calbiochem
(Merck) 234395] or rat serum (as a source of complement,
made in-house, not heat inactivated, kept at −80°C)
∼10 µg/ml laminin in PBS
Accutase
Dissecting microscope
Laminar flow hood
Humidified incubator at 7% CO2 and 37°C
Mouth pipette
Pasteur pipettes
Organ culture dishes
Tissue culture plastics
Protocol
1. Pre-equilibrate organ culture dishes containing KSOM (or
Blast) +1 µM PDO325901 and 3 µM CHIR99021 (2i/
KSOM) in the incubator for at least 15 min. Put PBS in
the outer well to prevent evaporation. Flush embryos from
oviducts using M2 medium at the 8-cell stage (Fig. 8A) and
place into pre-equilibrated 2i/KSOM for 1-2 days until
embryos reach the blastocyst stage (Fig. 8B). Note: Blast
media (Origio) can be used as an alternative, but N2B27 is
not suitable until after blastocyst cavitation.
2. Prepare and pre-equilibrate a fresh organ culture dish
containing 2i/LIF in N2B27 (LIF improves success rate, but
is not essential) in the central well and PBS in the outer well.
3. Transfer embryos (now at blastocyst stage) to the new dish.
4. Incubate for 1 or 2 more days, depending on when the
embryos were transferred to N2B27. A total of 3 days in
culture is optimal (Fig. 8C).
5. On day 3 of culture, pre-equilibrate an organ culture dish
containing N2B27+20% anti-mouse serum and three dishes
containing 400 µl N2B27 in the incubator. Also, gelatinise a
96-well plate. After 20 min, aspirate gelatine and add 200 µl
2i/LIF in N2B27. Leave in the incubator to pre-equilibrate.
6. If the embryos have not hatched, remove the zona pellucida
by use of acid Tyrode’s solution (Fig. 8D).
7. Place a drop (∼300 µl) of Tyrode’s solution on a sterile flat
dish.
8. Transfer embryos still contained within the zona pellucida to
Tyrode’s solution with minimal carry over and monitor
Fig. 7. Transfection efficiency as assessed by knockdown of GFP
in Rex1::GFPd2 cells. Left: representative flow cytometry profile. Right:
quantification of the percentage of Rex1::GFPd2 positive cells over four
independent experiments.
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under a dissection microscope until the zona has been
dissolved.
9. Once the zona is dissolved, wash embryos in one of the
dishes of N2B27.
10. Place embryos in a pre-equilibrated dish containing
N2B27+20% anti-mouse serum.
11. Incubate for 30 min to an hour or so in the incubator.
12. Rinse three times in pre-equilibrated N2B27 (or M2, if
preferred) by transferring embryos through drops.
13. Add 100 µl of freshly thawed rat serum or guinea pig
complement to pre-equilibrated 400 µl N2B27 to obtain a
20% solution (Fig. 8E,F). Incubate embryos in complement for
∼30 min until the trophectodermbegins to lyse (Fig. 8E). Use a
Pasteur pipette of the approximate size of the inner cell mass
(ICM) to remove it from the lysing trophectoderm (Fig. 8F).
14. Note: it is essential that the time between thawing and use is
kept to aminimumbecause the complement is highly unstable.
15. Place each isolated ICM into a well of the 96-well plate with
pre-equilibrated 2i/LIF in N2B27.
16. Incubate for 3-7 days, during which time each ICM will
form an ES-like colony (Fig. 8G).
17. To passage primary outgrowths, gently aspirate media
from wells, add 50µl Accutase per well of 96-well plate and
incubate for∼5 min until primary colonies detach. Add 100µl
of 2i/LIF, pipette up and down to obtain single cell
suspension, and transfer all content to a new laminin-coated
well of a 96-well plate. Next day, change medium to fresh 2i/
LIF. Repeat passaging procedure, progressively expanding
the line to 48-well, 24-well, etc. At the 24-well stage, passage
lines as indicated in ‘Propagation of ES cells without serum
factors or feeders’ section.
Batch testing N2B27
Three main tests are carried out on batches of N2B27 to determine
suitability for cell culture:
Colony-formation assay
See ‘Colony-formation assay’ section for a detailed protocol.
1. Culture cells in batches of 2i/LIF in N2B27 side-by-side for
two or three passages.
2. For testing, coat a 12-well plate with laminin (∼10 µg/ml in
PBS), three wells per batch.
3. Plate 400 cells/well in 2i/LIF+batch N2B27.
4. After 5 days, perform alkaline phosphatase staining according to
manufacturer’s instructions and count the number of colonies.
5. Good batches result in >80% clonogenicity.
Reporter assays
1. Culture Rex1::GFPd2 cells for two or three passages in 2i
batch-N2B27.
2. Analyse by flow cytometry.
3. Good batches result in log-normal distributions.
4. Note: Other cell lines can be used but if the reporter protein is
not destabilised (i.e. has a long half-life) cells have to be
cultured for longer periods. If reporter cells are not available,
immunostaining for Nanog can also be performed. Good
batches result in relatively uniform Nanog expression across
all cells.
Fig. 8. ES cell derivation process in 2i/LIF.
(A) Flushed 8-cell embryo. (B) Embryos after
1-2 days in culture. (C) After 3 days in culture,
embryos start to hatch from the zona
pellucida. (D) Hatched blastocyst (bottom)
and discarded zona (top). (E) Summary
of immunosurgery protocol and image of
ideal end-point after complement treatment.
(F) Separation of ICM and trophectoderm
after immunosurgery. (G) Primary outgrowth
cultured for 4 days in 2i/LIF on gelatinised
plates (not to scale with embryos). Images
reproduced with permission fromCold Spring
Harbor Laboratory Press. These images are
not published under the terms of the CC-BY
licence of this article. For permission to
reuse, please see Nichols and Jones, 2017.
TE, trophectoderm.
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Cell survival during differentiation
Although most batches will enable self-renewal of ES cells,
differentiation requires specific attention.
1. Follow neural differentiation protocol above and examine
cells on day 3-4.
2. Good batches of N2B27 show little cell death until cells reach
confluence. Death on day 2-3 is evident in poor batches.
Troubleshooting tips
Some useful troubleshooting tips are presented in Table 2.
Conclusions
In this paper, we have aimed to provide an accessible and
comprehensive set of step-by-step protocols, including all media
formulations, to facilitate robust and standardised manipulation of
mouse ES cells in defined conditions. We provide guidelines for
quality control and troubleshooting tips. The indicated reporter cell
lines for calibration are available from the authors. We highlight
key parameters that may perturb ES cell behaviour and genetic
integrity. In particular, we emphasise the requirement for timely
passaging to avoid overgrowth of colonies. Feedback on these
protocols and recommendations for further improvement are
welcome.
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Mahapatra, S., Tam, A., Laird, D. J., Hirst, M., Rao, A. et al. (2013). Vitamin C
induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells.
Nature 500, 222-226.
Boroviak, T., Loos, R., Bertone, P., Smith, A. andNichols, J. (2014). The ability of
inner-cell-mass cells to self-renew as embryonic stem cells is acquired following
epiblast specification. Nat. Cell Biol. 16, 516-528.
Bradley, A., Evans, M., Kaufman, M. H. and Robertson, E. (1984). Formation of
germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309,
255-256.
Brook, F. A. and Gardner, R. L. (1997). The origin and efficient derivation of
embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 94, 5709-5712.
Buehr, M., Meek, S., Blair, K., Yang, J., Ure, J., Silva, J., McLay, R., Hall, J., Ying,
Q.-L. and Smith, A. (2008). Capture of authentic embryonic stem cells from rat
blastocysts. Cell 135, 1287-1298.
Capecchi, M. R. (2005). Gene targeting in mice: functional analysis of the
mammalian genome for the twenty-first century. Nat. Rev. Genet. 6, 507-512.
Carey, B. W., Finley, L. W. S., Cross, J. R., Allis, C. D. and Thompson, C. B.
(2014). Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem
cells. Nature 518, 413-416.
Chambers, I., Silva, J., Colby, D., Nichols, J., Nijmeijer, B., Robertson, M.,
Vrana, J., Jones, K., Grotewold, L. and Smith, A. (2007). Nanog safeguards
pluripotency and mediates germline development. Nature 450, 1230-1234.
Choi, J., Clement, K., Huebner, A. J., Webster, J., Rose, C. M., Brumbaugh, J.,
Walsh, R. M., Lee, S., Savol, A., Etchegaray, J.-P. et al. (2017a). DUSP9
modulates DNA hypomethylation in female mouse pluripotent stem cells. Cell
Stem Cell 20, 706-719.e7.
Choi, J., Huebner, A. J., Clement, K., Walsh, R. M., Savol, A., Lin, K., Gu, H., Di
Stefano, B., Brumbaugh, J., Kim, S. Y. et al. (2017b). Prolonged Mek1/2
Table 2. Troubleshooting tips
Problem Cause Solution
Colonies show poor
attachment and float
away
Residual dissociation media present. After spinning cell suspension with Accutase and wash buffer, make sure
no residue remains.
Alternatively, increase wash buffer volume.
If using trypsin, add 5% FCS to wash buffer.
Cells were overgrown/underfed; mistreatment
for one passage is enough to affect cells
permanently.
It is recommended to thaw a new vial of cells.
Genetic background, e.g. C57BL/6, non-129
containing mixed strains.
Increase gelatine concentration to 0.2% or add small amount to BSA
to medium.
Colonies are of different
sizes
Incomplete dissociation of colonies. Ensure single cell suspension when splitting cells. Verify under the
microscope after pipetting to dissociate and before transferring to tube
with 5× wash buffer.
Merging of colonies due to poor distribution. Ensure cells are evenly distributed before allowing them back in the
incubator. Avoid circular motions of the plate and open/close incubators
gently until cells have settled.
Flattened/differentiated
colonies
Cells grown at too high a density or starved. Although morphology can be recovered after plating at single cell density,
the damage to cells is normally irreversible. The main effect of
overgrowing cells is that they can no longer differentiate efficiently.
Thawing a new vial of cells is recommended.
Poor quality N2B27. Batch test N2B27.
11
STEM CELLS AND REGENERATION Development (2019) 146, dev173146. doi:10.1242/dev.173146
D
E
V
E
LO
P
M
E
N
T
suppression impairs the developmental potential of embryonic stem cells. Nature
548, 219.
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X.,
Jiang, W., Marraffini, L. A. et al. (2013). Multiplex genome engineering using
CRISPR/cas systems. Science 339, 819-823.
Dean, W., Bowden, L., Aitchison, A., Klose, J., Moore, T., Meneses, J. J., Reik,
W. and Feil, R. (1998). Altered imprinted gene methylation and expression in
completely ES cell-derivedmouse fetuses: association with aberrant phenotypes.
Development 125, 2273-2282.
Dunn, S.-J., Martello, G., Yordanov, B., Emmott, S. and Smith, A. G. (2014).
Defining an essential transcription factor program for naïve pluripotency. Science
344, 1156-1160.
Evans, M. and Kaufman, M. (1981). Establishment in culture of pluripotential cells
from mouse embryos. Nature 292, 154-156.
Ficz, G., Hore, T. A., Santos, F., Lee, H. J., Dean, W., Arand, J., Krueger, F.,
Oxley, D., Paul, Y.-L., Walter, J. et al. (2013). FGF signaling inhibition in ESCs
drives rapid genome-wide demethylation to the epigenetic ground state of
pluripotency. Cell Stem Cell 13, 351-359.
Filipczyk, A., Marr, C., Hastreiter, S., Feigelman, J., Schwarzfischer, M., Hoppe,
P. S., Loeffler, D., Kokkaliaris, K. D., Endele, M., Schauberger, B. et al. (2015).
Network plasticity of pluripotency transcription factors in embryonic stem cells.
Nat. Cell Biol. 17, 1235-1246.
Freshney, R. I. (1994).Culture of Animal Cells: a Manual of Basic Technique. Wiley.
Habibi, E., Brinkman, A. B., Arand, J., Kroeze, L. I., Kerstens, H. H. D., Matarese,
F., Lepikhov, K., Gut, M., Brun-Heath, I., Hubner, N. C. et al. (2013). Whole-
genome bisulfite sequencing of two distinct interconvertible DNA methylomes of
mouse embryonic stem cells. Cell Stem Cell 13, 360-369.
Hackett, J. A., Kobayashi, T., Dietmann, S. and Surani, M. A. (2017). Activation of
lineage regulators and transposable elements across a pluripotent spectrum.
Stem Cell Rep. 8, 1645-1658.
Hayashi, K., Lopes, S., Tang, F. and Surani, M. (2008). Dynamic equilibrium and
heterogeneity of mouse pluripotent stem cells with distinct functional and
epigenetic states. Cell Stem Cell 3, 391-401.
Hayashi, K., Ohta, H., Kurimoto, K., Aramaki, S. and Saitou, M. (2011).
Reconstitution of the mouse germ cell specification pathway in culture by
pluripotent stem cells. Cell 146, 519-532.
Hayashi, K., Ogushi, S., Kurimoto, K., Shimamoto, S., Ohta, H. and Saitou, M.
(2012). Offspring from oocytes derived from in vitro primordial germ cell-like cells
in mice. Science 338, 971-975.
Huurne, T. M., Chappell, J., Dalton, S. and Stunnenberg, H. G. (2017). Distinct
cell-cycle control in two different states of mouse pluripotency. Cell Stem Cell 21,
449-455.e4.
Jakubczik, F., Jones, K., Nichols, J., Mansfield, W., Cooke, A. and Holmes, N.
(2016). A SNP in the immunoregulatory molecule CTLA-4 controls mRNA splicing
in vivo but does not alter diabetes susceptibility in the NOD mouse. Diabetes 65,
120-128.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A. andCharpentier, E.
(2012). A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science 337, 816-821.
Kalkan, T., Olova, N., Roode, M., Mulas, C., Lee, H. J., Nett, I., Marks, H., Walker,
R., Stunnenberg, H. G., Lilley, K. S. et al. (2017). Tracking the embryonic stem
cell transition from ground state pluripotency. Development 44, 1221-1234.
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